Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
REGN
Financials
Revenue by region
REGN
Regeneron Pharmaceuticals, Inc.
Backtest
REGN
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Revenue by region
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by region
Annual
Quarterly
Revenue by region
Annual
Quarterly
2025, ended Dec 31, 2025
United States
$10.2B
71%
Rest Of World
$508M
4%
Other
$3.7B
26%
Earlier:
ROW
to 2022
Regions by fiscal year
CSV
Regions by fiscal year
USD
Line, in USD
2025
2024
2023
2022
United States
10.2B
13.2B
12.6B
6.9B
Rest Of World
508M
430M
324M
—
Other
3.66B
0.60B
0.15B
5.21B
Earlier
ROW
—
—
—
73M
Total
14.3B
14.2B
13.1B
12.2B
More Regeneron Pharmaceuticals financials
Revenue
Revenue by product
Gross profit
Operating income
Net income
EPS
Revenue at other companies
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
ELV
Elevance Health, Inc.
HUM
Humana Inc.
HCA
HCA Healthcare, Inc.
AZN
AstraZeneca PLC
Tools
Return calculator